Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 4/2017

01-07-2017 | Special Feature

Breast reconstruction and postmastectomy radiotherapy: complications by type and timing and other problems in radiation oncology

Authors: Kenji Sekiguchi, Jiro Kawamori, Hideko Yamauchi

Published in: Breast Cancer | Issue 4/2017

Login to get access

Abstract

Breast reconstruction (BR) represents a suitable option for women who are not expected to require postmastectomy radiotherapy (PMRT). As recent evidence has led to an extension of the indications for PMRT, this has also appeared to increase the incidence of reconstructive complications. Nevertheless, in the USA at least, trends towards BR are changing. The frequency of immediate reconstruction continues to increase, even in the setting of PMRT. In immediate implant-based reconstruction, a staged approach is preferred. The failure rate of PMRT in implant patients is lower than that with expander patients. In delayed implant-based construction, tissue expansion of irradiated skin leads to a significantly increased risk of complications. In contrast, autologous tissue appears to tolerate radiation damage better than implant-based reconstructions. No significant differences have been described when complication rates of immediate autologous tissue BR with PMRT were compared with delayed autologous tissue BR following PMRT. In previously radiated patients, autologous tissue BR is preferred, and it may be safer when carried out ≥ 12 months after PMRT. Several other problems are associated with radiation delivery after BR and the clues to solve them are reviewed in this paper.
Literature
1.
Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, et al. An updated report on the trends in cancer incidence and mortality in Japan, 1958–2013. Jpn J Clin Oncol. 2015;45:390–401.CrossRefPubMed
2.
Kurebayashi J, Miyoshi Y, Ishikawa T, Saji S, Sugie T, Suzuki T, et al. Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011. Breast Cancer. 2015;22:235–44.CrossRefPubMed
3.
4.
Dean C, Chetty U, Forrest AP. Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet. 1983;1:459–62.CrossRefPubMed
5.
Gieni M, Avram R, Dickson L, Farrokhyar F, Lovrics P, Faidi S, et al. Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: a meta-analysis. Breast. 2012;21:230–6.CrossRefPubMed
6.
Barry M, Kell MR. Radiotherapy and breast reconstruction: a meta-analysis. Breast Cancer Res Treat. 2011;127:15–22.CrossRefPubMed
7.
EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.CrossRef
8.
NCCN. Clinical practice guidelines in oncology: breast cancer. version 2, 2016. Clinical practice guidelines in oncology: breast cancer version 2, 2016; 2016. http://​www.​nccn.​org/​.
9.
Jinno H, Inokuchi M, Ito T, Kitamura K, Kutomi G, Sakai T, et al. The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition. Breast Cancer. 2016;23:367–77.CrossRefPubMed
10.
Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32:919–26.CrossRefPubMedPubMedCentral
11.
Agarwal S, Kidwell KM, Farberg A, Kozlow JH, Chung KC, Momoh AO. Immediate reconstruction of the radiated breast: recent trends contrary to traditional standards. Ann Surg Oncol. 2015;22:2551–9.CrossRefPubMedPubMedCentral
12.
Frasier LL, Holden S, Holden T, Schumacher JR, Leverson G, Anderson B, et al. Temporal trends in postmastectomy radiation therapy and breast reconstruction associated with changes in national comprehensive cancer network guidelines. JAMA Oncol. 2016;2:95–101.CrossRefPubMedPubMedCentral
13.
El-Sabawi B, Sosin M, Carey JN, Nahabedian MY, Patel KM. Breast reconstruction and adjuvant therapy: a systematic review of surgical outcomes. J Surg Oncol. 2015;112:458–64.CrossRefPubMed
14.
Wilkins EG, Hamill JB, Kim HM, Kim JY, Greco RJ, Qi J, et al. Complications in postmastectomy breast reconstruction: One-year outcomes of the mastectomy reconstruction outcomes consortium (MROC) study. Ann Surg. 2016 (in press).
15.
Tsoi B, Ziolkowski NI, Thoma A, Campbell K, O’Reilly D, Goeree R. Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis. Plast Reconstr Surg. 2014;133:234–49.CrossRefPubMed
16.
Shah C, Kundu N, Arthur D, Vicini F. Radiation therapy following postmastectomy reconstruction: a systematic review. Ann Surg Oncol. 2013;20:1313–22.CrossRefPubMed
17.
Lam TC, Hsieh F, Boyages J. The effects of postmastectomy adjuvant radiotherapy on immediate two-stage prosthetic breast reconstruction: a systematic review. Plast Reconstr Surg. 2013;132:511–8.CrossRefPubMed
18.
Berbers J, van Baardwijk A, Houben R, Heuts E, Smidt M, Keymeulen K, et al. ‘Reconstruction: before or after postmastectomy radiotherapy?’ A systematic review of the literature. Eur J Cancer. 2014;50:2752–62.CrossRefPubMed
19.
Santosa KB, Chen X, Qi J, Ballard TN, Kim HM, Hamill JB, et al. Postmastectomy radiation therapy and two-stage implant-based breast reconstruction: is there a better time to irradiate? Plast Reconstr Surg. 2016;138:761–9.CrossRefPubMed
20.
Peled AW, Foster RD, Esserman LJ, Park CC, Hwang ES, Fowble B. Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure. Plast Reconstr Surg. 2012;130:503–9.CrossRefPubMed
21.
Lee KT, Mun GH. Prosthetic breast reconstruction in previously irradiated breasts: a meta-analysis. J Surg Oncol. 2015;112:468–75.CrossRefPubMed
22.
Yamauchi C, Sekiguchi K, Nishioka A, Arahira S, Yoshimura M, Ogo E, et al. The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition. Breast Cancer. 2016;23:378–90.CrossRefPubMed
23.
Berry T, Brooks S, Sydow N, Djohan R, Nutter B, Lyons J, et al. Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol. 2010;17(Suppl 3):202–10.CrossRefPubMed
24.
Fracol ME, Basta MN, Nelson JA, Fischer JP, Wu LC, Serletti JM, et al. Bilateral free flap breast reconstruction after unilateral radiation: comparing intraoperative vascular complications and postoperative outcomes in radiated versus nonradiated breasts. Ann Plast Surg. 2016;76:311–4.CrossRefPubMed
25.
Schaverien MV, Macmillan RD, McCulley SJ. Is immediate autologous breast reconstruction with postoperative radiotherapy good practice?: a systematic review of the literature. J Plast Reconstr Aesthet Surg. 2013;66:1637–51.CrossRefPubMed
26.
Rochlin DH, Jeong AR, Goldberg L, Harris T, Mohan K, Seal S, et al. Postmastectomy radiation therapy and immediate autologous breast reconstruction: integrating perspectives from surgical oncology, radiation oncology, and plastic and reconstructive surgery. J Surg Oncol. 2015;111:251–7.CrossRefPubMed
27.
Momoh AO, Colakoglu S, de Blacam C, Gautam S, Tobias AM, Lee BT. Delayed autologous breast reconstruction after postmastectomy radiation therapy: is there an optimal time? Ann Plast Surg. 2012;69:14–8.CrossRefPubMed
28.
Fosnot J, Fischer JP, Smartt JM Jr, Low DW, Kovach SJ 3rd, Wu LC, et al. Does previous chest wall irradiation increase vascular complications in free autologous breast reconstruction? Plast Reconstr Surg. 2011;127:496–504.CrossRefPubMed
29.
Baumann DP, Crosby MA, Selber JC, Garvey PB, Sacks JM, Adelman DM, et al. Optimal timing of delayed free lower abdominal flap breast reconstruction after postmastectomy radiation therapy. Plast Reconstr Surg. 2011;127:1100–6.CrossRefPubMed
30.
Cordeiro PG, Albornoz CR, McCormick B, Hu Q, Van Zee K. The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years. Plast Reconstr Surg. 2014;134:588–95.CrossRefPubMed
31.
Hickey BE, Francis DP, Lehman M. Sequencing of chemotherapy and radiotherapy for early breast cancer. Cochrane Database Syst Rev. 2013;4:CD005212.
32.
Olivotto IA, Lesperance ML, Truong PT, Nichol A, Berrang T, Tyldesley S, et al. Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. J Clin Oncol. 2009;27:16–23.CrossRefPubMed
33.
Tsoutsou PG, Koukourakis MI, Azria D, Belkacemi Y. Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives. Crit Rev Oncol Hematol. 2009;71:102–16.CrossRefPubMed
34.
Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21:555–63.CrossRefPubMed
35.
Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87:3–16.CrossRefPubMed
36.
Buchholz TA, Austin-Seymour MM, Moe RE, Ellis GK, Livingston RB, Pelton JG, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1993;26:23–35.CrossRefPubMed
37.
Metz JM, Schultz DJ, Fox K, Mathews A, Glick J, Solin LJ. Analysis of outcomes for high-risk breast cancer based on interval from surgery to postmastectomy radiation therapy. Cancer J. 2000;6:324–30.PubMed
38.
The International Commission on Radiation Units and Measurement. ICRU 50: prescribing, recording, and reporting photon beam therapy. Bethesda; 1993.
39.
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114:3–10.CrossRefPubMed
40.
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol. 2016;118:205–8.CrossRefPubMed
41.
42.
Massabeau C, Fournier-Bidoz N, Wakil G, Castro Pena P, Viard R, Zefkili S, et al. Implant breast reconstruction followed by radiotherapy: can helical tomotherapy become a standard irradiation treatment? Med Dosim. 2012;37:425–31.CrossRefPubMed
43.
Chatzigiannis C, Lymperopoulou G, Sandilos P, Dardoufas C, Yakoumakis E, Georgiou E, et al. Dose perturbation in the radiotherapy of breast cancer patients implanted with the Magna-Site: a Monte Carlo study. J Appl Clin Med Phys. 2011;12:3295.CrossRefPubMed
44.
Gee HE, Bignell F, Odgers D, Gill S, Martin D, Toohey J, et al. In vivo dosimetric impact of breast tissue expanders on post-mastectomy radiotherapy. J Med Imaging Radiat Oncol. 2016;60:138–45.CrossRefPubMed
45.
Damast S, Beal K, Ballangrud A, Losasso TJ, Cordeiro PG, Disa JJ, et al. Do metallic ports in tissue expanders affect postmastectomy radiation delivery? Int J Radiat Oncol Biol Phys. 2006;66:305–10.CrossRefPubMed
46.
Buchholz TA, Kronowitz SJ, Kuerer HM. Immediate breast reconstruction after skin-sparing mastectomy for the treatment of advanced breast cancer: radiation oncology considerations. Ann Surg Oncol. 2002;9:820–1.CrossRefPubMed
47.
Marks LB, Bentel GC, Hardenbergh PH, Lind PA, Prosnitz LR, Ollino P. A practical and easy method to locate the first three internal mammary lymph node-bearing areas [An easy and practical method for quantitative and qualitative measurement of ultraviolet radiation.]. Int J Radiat Oncol Biol Phys. 2001;50:421–5.CrossRefPubMed
48.
Motwani SB, Strom EA, Schechter NR, Butler CE, Lee GK, Langstein HN, et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:76–82.CrossRefPubMed
49.
Ohri N, Cordeiro PG, Keam J, Ballangrud A, Shi W, Zhang Z, et al. Quantifying the impact of immediate reconstruction in postmastectomy radiation: a large, dose-volume histogram-based analysis. Int J Radiat Oncol Biol Phys. 2012;84:e153–9.CrossRefPubMed
50.
Chung E, Marsh RB, Griffith KA, Moran JM, Pierce LJ. Quantifying dose to the reconstructed breast: can we adequately treat? Med Dosim. 2013;38:55–9.CrossRefPubMed
51.
Thomas K, Rahimi A, Spangler A, Anderson J, Garwood D. Radiation practice patterns among United States radiation oncologists for postmastectomy breast reconstruction and oncoplastic breast reduction. Pract Radiat Oncol. 2014;4:466–71.CrossRefPubMed
52.
Chen SA, Hiley C, Nickleach D, Petsuksiri J, Andic F, Riesterer O, et al. Breast reconstruction and post-mastectomy radiation practice. Radiat Oncol. 2013;8:45.CrossRefPubMedPubMedCentral
53.
Matsunuma R, Oguchi M, Fujikane T, Matsuura M, Sakai T, Kimura K, et al. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes. Int J Radiat Oncol Biol Phys. 2012;83:845–52.CrossRefPubMed
54.
Bouganim N, Tsvetkova E, Clemons M, Amir E. Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research. Breast Cancer Res Treat. 2013;139:603–6.CrossRefPubMed
55.
McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, et al. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys. 2014;89:392–8.CrossRefPubMed
56.
Imoto S, Yamauchi C, Komoike Y, Tsugawa K, Yotsumoto D, Wada N, et al. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society. Breast Cancer. 2016 (in press).
57.
Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.CrossRefPubMed
58.
Thorsen LB, Offersen BV, Dano H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016;34:314–20.CrossRefPubMed
59.
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373:307–16.CrossRefPubMedPubMedCentral
60.
Kunkler I, van Tienhoven G, Dixon M, Robin Prescott R, Russell N, Peter Canney P, et al. Postmastectomy radiotherapy should not be standard of care for women with 1–3 involved nodes. Radiother Oncol. 2007;84:103–4.CrossRef
61.
Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer. 2006;106:4–16.CrossRefPubMed
62.
Wang F, Peled AW, Chin R, Fowble B, Alvarado M, Ewing C, et al. The impact of radiation therapy, lymph node dissection, and hormonal therapy on outcomes of tissue expander-implant exchange in prosthetic breast reconstruction. Plast Reconstr Surg. 2016;137:1–9.CrossRefPubMed
63.
Kronowitz SJ, Hunt KK, Kuerer HM, Babiera G, McNeese MD, Buchholz TA, et al. Delayed-immediate breast reconstruction. Plast Reconstr Surg. 2004;113:1617–28.CrossRefPubMed
64.
Wang J, Li X, Deng Q, Xia B, Wu S, Liu J, et al. Postoperative radiotherapy following mastectomy for patients with left-sided breast cancer: a comparative dosimetric study. Med Dosim. 2015;40:190–4.CrossRefPubMed
65.
Meyer E, Raupach R, Lell M, Schmidt B, Kachelriess M. Normalized metal artifact reduction (NMAR) in computed tomography. Med Phys. 2010;37:5482–93.CrossRef
66.
Kassim I, Joosten H, Barnhoorn JC, Heijmen BJ, Dirkx ML. Implications of artefacts reduction in the planning CT originating from implanted fiducial markers. Med Dosim. 2011;36:119–25.CrossRefPubMed
67.
Mizuno N, Takahashi H, Kawamori J, Niibe Y, Nakamura N, Ogita M, et al. Effect of metallic ports in tissue expanders on postmastectomy radiation dose distribution. In: Proceedings of the 27th annual meeting of the Japanese Society for Radiation Oncology; 2014. p. 286 (in Japanese).
Metadata
Title
Breast reconstruction and postmastectomy radiotherapy: complications by type and timing and other problems in radiation oncology
Authors
Kenji Sekiguchi
Jiro Kawamori
Hideko Yamauchi
Publication date
01-07-2017
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2017
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-017-0754-3

Other articles of this Issue 4/2017

Breast Cancer 4/2017 Go to the issue

Original Article

Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip®) placed in phantoms and patients

Original Article

Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients

Original Article

Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk

Special Feature

Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements

Special Feature

Post-mastectomy radiation therapy in breast cancer with 1–3 involved lymph nodes: the Pros

Original Article

Accuracy assessment methods of tissue marker clip placement after 11-gauge vacuum-assisted stereotactic breast biopsy: comparison of measurements using direct and conventional methods
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits